Jeremie H. Estepp, MD
Jeremie H. Estepp, MD

Jeremie H. Estepp, MD

Assistant Member, St. Jude Faculty

Departments

Divisions

Education

BA – Carson-Newman College, Jefferson City, Tennessee
MD – Joan C. Edwards School of Medicine, Marshall University, Huntington, West Virginia
Internship/Residency – University of Tennessee, LeBonheur Children’s Hospital
Fellowship (Pediatric Hematology/Oncology) – St. Jude Children’s Research Hospital

Research Interests

  • Thrombosis
  • Bleeding disorders
  • Sickle Cell Disease 

Selected Publications

Cancio MI, Aygun B, Chui DHK, Rothman JA, Scott JP, Estepp JH, Hankins JS. The clinical severity of hemoglobin S/Black (A ???)0 -thalassemia. Pediatr Blood Cancer Apr 28, 2017. Epub ahead of print]

Gammal RS, Crews KR, Haidar CE, Hoffman JM, Baker DK, Barker PJ, Estepp JH, Pei D, Broeckel U, Wang W, Weiss MJ, Relling MV, Hankins J. Pharmacogenetics for safe codeine use in sickle cell disease. Pediatrics 138(1), 2016.

Estepp JH, Melloni C, Thornburg CD, Wiczling P, Rogers Z, Rothman JA, Green NS, Liem R, Brandow AM, Crary SE, Howard TH, Morris MH, Lewandowski A, Garg U, Jusko WJ, Neville KA. Pharmacokinetics and bioequivalence of a liquid formulation of hydroxyurea in children with sickle cell anemia. J Clin Pharmacol 56(3):298-306, 2015.

Estepp JH, Winter B, Johnson M, Smeltzer MP, Howard SC, Hankins JS. Improved hydroxyurea effect with the use of text messaging in children with sickle cell anemia. Pediatr Blood Cancer 61(11):2031-36, 2014.

Estepp JH, Smeltzer MP, Wang WC, Hoehn ME, Hankins JS, Aygun B. Protection from sickle cell retinopathy is associated with elevated HbF levels and hydroxycarbamide use in children. Br J Haematol 161(3):402-405, 2013.

Estepp JH, Smeltzer M, Reiss UM. The impact of quality and duration of enoxaparin therapy on recurrent venous thrombosis in children. Pediatr Blood Cancer 59(1):105-109, 2012.

Last update: August 2017